pharmaceuticals
FDA awards orphan status to new brain cancer vaccine
August 9, 2017Research and Development, Sales and Marketing FDA, life sciences, orphan drug, pharma, pharmaceuticals
The FDA has announced that it has awarded orphan drug status to the vaccine SurVaxM for patients with glioblastoma, the …
Merck scores expanded NICE recommendation in head, neck and oral cancer
August 8, 2017Manufacturing and Production, Sales and Marketing Erbitux, Merck, NICE, biotech, cetuximah, drugs, life sciences, pharma, pharmaceuticals
Merck has announced its approval of NICE’s decision to expand its recommendation of Erbitux (cetuximab) to include its use as …
NICE recommends plaque psoriasis contender for NHS use
August 8, 2017Manufacturing and Production, Sales and Marketing Almirall, NICE< Skilarence, drugs, life sciences, medicine, pharma, pharmaceuticals, plaque psoriasis, psoriasis
The use of Almirall’s psoriasis drug Skilarence (dimethyl fumarate) on the UK’s NHS is one step closer after NICE gave …
Stomach acid drugs do not increase Alzheimer’s risk, study confirms
August 7, 2017Research and Development, Sales and Marketing Alzheimer's, dementia, drugs, healthcare, lansoprazole, life sciences, medicine, omeprazole, pharma, pharmaceuticals, proton pump inhibitors
A new study from the University of Eastern Finland has indicated that the use of proton pump inhibitors such as …
Top Ten most popular articles on Pharmafile.com this week
August 4, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, biotech, drugs, healthcare, life sciences, medicines, pharma, pharmaceuticals, top ten
Another week passes by, and the headlines have seen some shocking stories, such as the news that the UK is …
NICE greenlights Celgene pancreatic cancer drug as first-line combination treatment
August 4, 2017Medical Communications, Sales and Marketing Cancer, Celgene, NICE, Pancreatic cancer, drugs, healthcare, life sciences, medicine, pharma, pharmaceuticals
Celgene is celebrating following NICE’s announcement that it had decided to recommend the use of nab-Paclitaxel, when used in combination …
FDA turns down Janssen’s sirukumab for rheumatoid arthritis
August 3, 2017Sales and Marketing FDA, Janssen, drugs, life sciences, medicine, pharma, pharmaceuticals, rheumatoid arthritis, sirukumab
Janssen has announced that it has suffered a knockback to its plans to commercialise sirukumab in the US in the …
FDA approves Celgene and Agios’ acute myeloid leukaemia drug
August 2, 2017Research and Development, Sales and Marketing Celgene, FDA, Idhifa, acute myeloid leukaemia, agios, biotech, drugs, life sciences, medicines, pharma, pharmaceuticals
The FDA has given its approval for the commercialisation of Celgene and Agios Pharmaceutical’s Idhifa for the treatment of relapsed …
Brexit Health Alliance warns that UK/EU negotiations put patients at risk
August 1, 2017Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BioIndustry Association, Brexit Health Alliance, NHS, brexit, drugs, healthcare, life sciences, pharma, pharmaceuticals
Last month saw the formation of the Brexit Health Alliance, a partnering of key pharma and life sciences organisations including …
Strong Q2 growth for Sanofi raises 2017 sales outlook
July 31, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dupixient, Sanofi, biotech, drugs, healthcare, pharma, pharmaceuticals
Sanofi exuded renewed confidence in its updated forecast for 2017 on the back of a Q2 report which illustrated strong …
Department of Health appoints Teva and Sanofi veteran as commercial head
July 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Department of Health, Sanofi, Teva, biotech, drugs, government, healthcare, pharma, pharmaceuticals
The UK Government has announced a new appointment within the Department of Health: Steve Oldfield, a former veteran of Teva …
New research reveals genetic mutations in smoking-related cancers
July 27, 2017Research and Development Cancer, biotech, drugs, health, pharma, pharmaceuticals
Researchers at the Wake Forest School of Medicine in the US have made a big discovery which could help explain …
Janssen single tablet regimen shows Phase 3 success in HIV
July 26, 2017Research and Development HIV, Janssen, biotech, healthcare, pharma, pharmaceuticals
The latest Phase 3 data investigating Janssen’s darunivir in the treatment of human immunodeficiency virus (HIV-1) showed that the drug …
Monthly injectable HIV treatment proves as effective as traditional daily pill regimen
July 24, 2017Research and Development, Sales and Marketing AIDS, HIV, Janssen, ViiV Healthcare, biotech, drugs, pharma, pharmaceuticals
New early trial data suggests that current daily HIV pill regimens could be replaced with injections which slowly release medication …
GSK continues restructure by axing £350m Cumbria plant plans
July 21, 2017Manufacturing and Production, Medical Communications GSK, GlaxoSmithKline, UK, biotech, drugs, pharma, pharmaceuticals
Just days after UK pharma giant GSK announced it would be selling off its Horlicks brand to focus on its …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
